Brief introduction of Beijing Kexing
Beijing Kexing is a biotechnology high-tech enterprise jointly funded by Shenzhen Kexing Bioengineering Co., Ltd., Tangshan Yi 'an Bioengineering Co., Ltd. and Hong Kong Huading Pharmaceutical Co., Ltd. of Peking University. It was incorporated in Beijing Zhongguancun Science Park on 200 1 with a registered capital of 1 100 million yuan and a total investment of1500 million yuan.
The purpose of the company's establishment and operation is: based on the desire to develop China's bioengineering high-tech industry, adopt advanced scientific and technological achievements at home and abroad, introduce international scientific management methods, research, produce and sell vaccines for human use and related products, provide technical consultation and technical services, improve the prevention and treatment level of various major diseases at home and abroad, including hepatitis A and hepatitis B, and make contributions to human health.